Lead Pharma Medicine B.V.
Closed bankruptcy- KvK
- 09172969
- Establishment
- Oss, Noord-Brabant
- Sector
- Not known
- Court
- Oost-Brabant
- Bankruptcy number
- F.01/25/159
- Judgment
- June 17, 2025
- Insolvency practitioner
- mr. D.P. Schalken, BG.Legal
Summary
On June 17, 2025, the Rechtbank Oost-Brabant declared Lead Pharma Medicine B.V. bankrupt (insolvency number F.01/25/159). The proceedings ended on September 29, 2026. It is a BV from Oss (Noord-Brabant). Its KvK number is 09172969. mr. D.P. Schalken (BG.Legal) has been appointed insolvency practitioner. mr. S.C.E.F. Moulen Janssen has been appointed supervisory judge. There are 4 public reports; the latest is report 4 of April 8, 2026. In addition, there are 5 financial reports; the latest is financial report of August 11, 2026. Estate assets according to financial report 4: €315,857.06. Key figures according to report 4: unsecured claims €680,175.99, creditors 21 en preferential claims €580,086.57. Status according to report 4: completed: causes of the bankruptcy; no indications according to the insolvency practitioner: legal proceedings.
Noord-Brabant recorded 481 bankruptcies in the past twelve months. Of these, 18 came from the municipality of Oss.
Employees according to report 4 of April 8, 2026: 18.
The procedure ended on September 29, 2026. The termination notice and any final reports describe how the case was concluded; termination does not automatically mean that all creditors have been paid.
New since report 4
8 changesPublic report 4 of April 8, 2026, compared with report 3 of January 14, 2026
Changed
€669,975.99€680,175.99191 h 48 min221 h 12 min2021
Completed
Further case information
Status
- Rent and lease
- Mentioned Rent and lease
- Causes of the bankruptcy
- Completed Causes of the bankruptcy
-
Tot heden is de curator het volgende gebleken uit gesprekken met het bestuur en betrokkenen, maar dit vormt geen conclusie. Lead Pharma Medicine B.V. exploiteert een farmaceutisch onderzoeks- en ontw ikkelbedrijf. Daartoe verricht zij onderzoek naar nieuw e medicijnen ter genezing van kanker en auto-immuunziekten. Medicijnonderzoek is een langdurig en kostbaar traject. Van een idee naar verkoop du
- Staff
- Mentioned Staff
- Sale of assets
- Mentioned Sale of assets
- Collection of receivables
- Mentioned Collection of receivables
- Security rights
- Mentioned Security rights
- Bookkeeping obligation
- Mentioned Bookkeeping obligation
- Filing of annual accounts
- Completed Filing of annual accounts
- Director liability
- Mentioned Director liability
- Actio pauliana
- Mentioned Actio pauliana
- Legal proceedings
- No indications Legal proceedings
- Lawfulness investigation
- Mentioned Lawfulness investigation
Recent timeline
-
Financial data changed in report 4
Key documents
- View
Opheffing faillissement wegens gebrek aan baten op 29 september 2026
09-30-2026 1 p. Central Insolvency Register
- View
Financieel verslag 04-08-2026
08-11-2026 10 p. Rechtspraak
- View
Vereenvoudigde afwikkeling van het faillissement
05-13-2026 1 p. Central Insolvency Register
- View
Verslag: 08-04-2026
04-08-2026 17 p. Rechtspraak
What you want to know about Lead Pharma Medicine B.V.
Who is the bankruptcy trustee of Lead Pharma Medicine B.V.?
The Rechtbank Oost-Brabant has appointed mr. D.P. Schalken of BG.Legal as bankruptcy trustee. For questions about the bankruptcy, please contact the bankruptcy trustee.
On what date did Lead Pharma Medicine B.V. go bankrupt?
Lead Pharma Medicine B.V. was declared bankrupt by the Rechtbank Oost-Brabant on June 17, 2025. The case has insolvency number F.01/25/159.
How does the bankruptcy of Lead Pharma Medicine B.V. affect creditors?
In a bankruptcy the company may no longer dispose of its assets itself. The insolvency practitioner manages and sells the assets and distributes the proceeds among the creditors according to the statutory ranking. Whether and how much ordinary creditors receive usually only becomes clear at the end.
Are there public reports on the bankruptcy?
Yes, there are 4 public reports; the most recent is from April 8, 2026. You can find them under Reports in this case.
Company details
- Legal form
- BV
Sources
Not known: sbi code, founded, kvk registration, trade names
Addresses
Affiliated companies
- Parent company (sole shareholder) Lead Pharma Holding B.V. Ongoing report 1
Possibly relevant announcements
Found on the basis of the company name.
- Rechtbank Oost-Brabant; Faillissementen,surseances en schuldsaneringen faillissement, surseance van betaling of schuldsanering, October 1, 2026
- Autoriteit Nucleaire Veiligheid en Stralingsbescherming heeft, onder het daarbij vermelde kenmerk, vergunningen verleend voor het verrichten van handelingen met radioactieve stoffen, versnellers, toestellen en splijtstoffen. Onderstaande vergunningen zijn voorbereid met toepassing van Titel 4.1 van de Algemene wet bestuursrecht andere vergunning, July 25, 2025
- Autoriteit Nucleaire Veiligheid en Stralingsbescherming heeft, onder het daarbij vermelde kenmerk, vergunningen verleend voor het verrichten van handelingen met radioactieve stoffen, versnellers, toestellen en splijtstoffen. Onderstaande vergunningen zijn voorbereid met toepassing van Titel 4.1 van de Algemene wet bestuursrecht. Vergunningen, March 12, 2021